Clinical trials recruiting in Waltham, Massachusetts
31
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 3Phase 3 13Not applicable 14
Conditions recruiting in Waltham, Massachusetts
Recruiting trials in Waltham, Massachusetts
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
- A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
- A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
- Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis
- CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
- CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
- CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
- CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
- IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry
- PPDTM CorEvitasTM Obesity (OBR) Drug Effectiveness and Safety Registry
- PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
- PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Symptom Monitoring in Hemodialysis
- The CorEvitas Psoriasis (PSO) Registry
Common questions
How many clinical trials are recruiting in Waltham, Massachusetts?
31 recruiting trials have at least one study site in Waltham, Massachusetts.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.